Geneoscopy closes $105 M in series C funding round to power next-generation of gastrointestinal diagnostic tests
Tehnologie
Geneoscopy, Inc. Jan 9 2025 Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 million. Bio-Rad Laboratories led the financing and was joined by Petrichor, Labcorp, Morningside Ventures, Lightchain Capital, NT Investments, Granger Management and Mercy Health, Tri Locum Partners, and others. The capital raise positions the company to achieve key
din zilele anterioare